# Genomelink **Source:** https://geo.sig.ai/brands/genomelink **Vertical:** Healthcare **Subcategory:** General **Tier:** Emerging **Website:** genomelink.io **Last Updated:** 2026-04-14 ## Summary DNA app store enabling users to upload Ancestry/23andMe raw data for additional trait and health insights; $3.3M revenue positioned to capture 23andMe users after its 2024 bankruptcy filing. ## Company Overview Genomelink is a San Francisco-based DNA app store and personalized genomics platform that allows users to upload raw DNA data from Ancestry, 23andMe, or other consumer DNA tests and access a marketplace of analysis apps covering ancestry, traits, health predispositions, and wellness insights. Founded in 2017 and backed by $4.5-9 million from 500 Global, Asymmetry Ventures, and 27 total investors, Genomelink generated $3.3 million in revenue in 2024 with a 22-person team, serving consumers who want more from their raw genetic data than the original testing company provides. Genomelink's platform enables third-party developers to build apps on top of user DNA data through its API and app store model — similar to how the iPhone App Store enables a developer ecosystem, Genomelink enables genomics app developers to reach users who have already paid for sequencing and want additional insights. Users grant permissions for specific apps to access their genetic data, and Genomelink handles the security, privacy, and data processing infrastructure. Apps cover trait prediction (athletic potential, food preferences, sleep chronotype), ancestry analysis beyond what 23andMe or Ancestry provides, and carrier status for genetic conditions. In 2025, Genomelink competes in the consumer genomics and genetic insights market with Ancestry (the dominant US family history and DNA platform), 23andMe (which filed for bankruptcy protection in 2024, later acquired), and LifeDNA (similar DNA insights marketplace) for consumers seeking personalized genetics insights. 23andMe's bankruptcy creates market opportunity — millions of 23andMe users who want to keep using their existing raw DNA data need alternatives to the 23andMe app, and Genomelink can serve these users by importing their existing raw DNA files. The 2025 strategy focuses on growing the 23andMe user migration opportunity, expanding the developer app ecosystem, and adding health and wellness tracking features that use genetic data to personalize lifestyle recommendations. ## Frequently Asked Questions ### What is Genomelink? Genomelink is a DNA App Store company founded in 2017 that enables users to upload their genetic data from DNA tests like Ancestry or 23andMe to unlock a wide range of DNA apps. The platform provides access to ancestry breakdowns, genetic traits analysis, DNA matching features, and personalized genomics insights. ### What products and services does Genomelink offer? Genomelink offers DNA data analysis, genetic traits exploration, ancestry breakdown tools, DNA matching features, and a genetic app marketplace. The platform also provides genetic health reports, trait prediction algorithms, and personalized genomics insights through a third-party DNA upload platform. ### Who is Genomelink for? Genomelink is designed for individuals who have already taken DNA tests from services like Ancestry or 23andMe and are seeking deeper genetic insights. The platform serves consumers globally who want to explore their genetic data beyond their initial DNA test results. ### When was Genomelink founded? Genomelink was founded in 2017. The company later participated in Y Combinator's S21 batch. ### Where is Genomelink located? Genomelink is based in the United States. The company operates in the Healthcare Tech industry. ### How much funding has Genomelink raised? Genomelink has raised between $4.49M and $9M in total funding, with sources varying on the exact amount. The company completed a Seed II funding round in July 2023 and has 27 investors including 500 Global, Asymmetry Ventures, Brighter Capital, Darwin, and Metaplanet Holdings. ### What are Genomelink's key achievements and metrics? Genomelink achieved $3.3M in revenue in 2024 and currently employs 22 people. The company has attracted 27 investors and was accepted into Y Combinator's S21 batch. ### How does Genomelink's technology work? Genomelink operates as a third-party DNA upload platform that allows users to upload their existing genetic data from services like Ancestry or 23andMe. The platform then uses trait prediction algorithms and provides access to various DNA apps for analyzing genetic traits, ancestry, and health information. ### How can I get started with Genomelink? To get started with Genomelink, users need to have already taken a DNA test from services like Ancestry or 23andMe. They can then upload their genetic data to Genomelink's platform to unlock and access various DNA apps and genetic insights. ### What are the latest developments at Genomelink? Genomelink completed a Seed II funding round in July 2023 and achieved $3.3M in revenue in 2024. The company continues to operate as a DNA App Store for users with Ancestry and 23andMe data, backed by 27 investors including notable firms like 500 Global and Asymmetry Ventures. ## Tags healthtech, saas, global, b2b --- *Data from geo.sig.ai Brand Intelligence Database. Updated 2026-04-14.*